Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 16Vincristine 12Doxorubicin 11Radiotherapy 10Etoposide 9Prednisone 8Peripheral Blood Stem Cell Transplantation 8VAP-cyclo protocol 6Filgrastim 6Rituximab 5Mitoxantrone 5Melphalan 5Cytarabine 5Carmustine 4Bleomycin 4Prednisolone 3Methylprednisolone 3Methotrexate 3Idarubicin 3liposomal amphotericin B 2aldesleukin 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Leucovorin 2Interferon-alpha 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Epoetin Alfa 2Early Intervention, Educational 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large-Cell, Immunoblastic × Mesna × Clear all
NCT00002565 2018-11-14

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

M.D. Anderson Cancer Center

Phase 3 Completed
61 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡